These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1701170)

  • 1. Conformation of apolipoprotein B-100 in the low density lipoproteins of tangier disease. Identification of localized conformational response to triglyceride content.
    Kunitake ST; Young SG; Chen GC; Pullinger CR; Zhu S; Pease RJ; Scott J; Hass P; Schilling J; Kane JP
    J Biol Chem; 1990 Dec; 265(34):20739-46. PubMed ID: 1701170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary sequence mapping of human apolipoprotein B-100 epitopes. Comparisons of trypsin accessibility and immunoreactivity and implication for apoB conformation.
    Chen PF; Marcel YL; Yang CY; Gotto AM; Milne RW; Sparrow JT; Chan L
    Eur J Biochem; 1988 Jul; 175(1):111-8. PubMed ID: 2456922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Well-defined regions of apolipoprotein B-100 undergo conformational change during its intravascular metabolism.
    Wang X; Pease R; Bertinato J; Milne RW
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1301-8. PubMed ID: 10807746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified lipid-protein interactions in Tangier beta lipoprotein (LDL2) demonstrated by fluorescence quenching.
    Dumon MF; Dang QQ; Salvayre R; Clerc M; Douste-Blazy L
    Chem Phys Lipids; 1988 Dec; 49(3):153-60. PubMed ID: 3240561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in local conformation in human apolipoprotein B-100 of plasma low density and very low density lipoproteins as identified by cathepsin D.
    Chen GC; Lau K; Hamilton RL; Kane JP
    J Biol Chem; 1991 Jul; 266(19):12581-7. PubMed ID: 2061328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma triglycerides determine low density lipoprotein composition, physical properties, and cell-specific binding in cultured cells.
    McKeone BJ; Patsch JR; Pownall HJ
    J Clin Invest; 1993 May; 91(5):1926-33. PubMed ID: 8387537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of the plasma very low and low density lipoproteins in Tangier disease.
    Heinen RJ; Herbert PN; Fredrickson DS
    J Clin Invest; 1978 Jan; 61(1):120-32. PubMed ID: 201668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes.
    Wang CS; Alaupovic P; Gregg RE; Brewer HB
    Biochim Biophys Acta; 1987 Jul; 920(1):9-19. PubMed ID: 3109493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of monoclonal antibodies to localize the low density lipoprotein receptor-binding domain of apolipoprotein B.
    Milne R; Théolis R; Maurice R; Pease RJ; Weech PK; Rassart E; Fruchart JC; Scott J; Marcel YL
    J Biol Chem; 1989 Nov; 264(33):19754-60. PubMed ID: 2479639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of the triglyceride content of low density lipoprotein on the interaction of apolipoprotein B-100 with cells.
    Aviram M; Lund-Katz S; Phillips MC; Chait A
    J Biol Chem; 1988 Nov; 263(32):16842-8. PubMed ID: 3182816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemical study of the plasma low and high density lipoproteins in Tangier disease.
    Dumon MF; Visvikis S; Manabe T; Clerc M
    FEBS Lett; 1986 May; 201(1):163-7. PubMed ID: 3086124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypolipidemic therapy modulates expression of apolipoprotein B epitopes on low density lipoproteins. Studies in mild to moderate hypertriglyceridemic patients.
    Kleinman Y; Schonfeld G; Gavish D; Oschry Y; Eisenberg S
    J Lipid Res; 1987 May; 28(5):540-8. PubMed ID: 2439628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of apoprotein B conformation on the activation of lysolecithin acyltransferase and lecithin: cholesterol acyltransferase. Studies with subfractions of low density lipoproteins.
    Liu M; Krul ES; Subbaiah PV
    J Biol Chem; 1992 Mar; 267(8):5139-47. PubMed ID: 1544896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of apolipoprotein B100 polymorphisms that affect low-density lipoprotein metabolism: description of a new approach involving monoclonal antibodies and dynamic light scattering.
    Chatterton JE; Schlapfer P; Bütler E; Gutierrez MM; Puppione DL; Pullinger CR; Kane JP; Curtiss LK; Schumaker VN
    Biochemistry; 1995 Jul; 34(29):9571-80. PubMed ID: 7626627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lipid transfer activity and triglyceride hydrolysis on apolipoprotein B immunoreactivity in modified low density lipoproteins.
    Viens L; Lagrost L
    J Lipid Res; 1997 Jun; 38(6):1129-38. PubMed ID: 9215541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition of a nonlinear conformational epitope for the apolipoprotein B-100-specific monoclonal antibody, MB47.
    Young SG; Koduri RK; Austin RK; Bonnet DJ; Smith RS; Curtiss LK
    J Lipid Res; 1994 Mar; 35(3):399-407. PubMed ID: 7516960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a monoclonal antibody-based enzyme-linked immunosorbent assay as a candidate reference method for the measurement of apolipoprotein B-100.
    Albers JJ; Lodge MS; Curtiss LK
    J Lipid Res; 1989 Sep; 30(9):1445-58. PubMed ID: 2600545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning and expression of partial cDNAs and deduced amino acid sequence of a carboxyl-terminal fragment of human apolipoprotein B-100.
    Wei CF; Chen SH; Yang CY; Marcel YL; Milne RW; Li WH; Sparrow JT; Gotto AM; Chan L
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7265-9. PubMed ID: 2932736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein B, the major protein component of triglyceride-rich and low density lipoproteins.
    Chan L
    J Biol Chem; 1992 Dec; 267(36):25621-4. PubMed ID: 1464582
    [No Abstract]   [Full Text] [Related]  

  • 20. Conformational differences in human apolipoprotein B-100 among subspecies of low density lipoproteins (LDL). Association of altered proteolytic accessibility with decreased receptor binding of LDL subspecies from hypertriglyceridemic subjects.
    Chen GC; Liu W; Duchateau P; Allaart J; Hamilton RL; Mendel CM; Lau K; Hardman DA; Frost PH; Malloy MJ
    J Biol Chem; 1994 Nov; 269(46):29121-8. PubMed ID: 7961878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.